What are the clinical signs and symptoms of Enterococcus infection and the recommended treatment regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Signs and Symptoms of Enterococcus Infection and Treatment

Clinical Manifestations

Enterococcus infections present with diverse clinical manifestations depending on the site of infection, ranging from indolent community-acquired infections to severe nosocomial sepsis.

Common Infection Sites and Presentations:

Urinary Tract Infections (most common):

  • Dysuria, frequency, urgency, suprapubic pain
  • Pyelonephritis: fever, flank pain, costovertebral angle tenderness
  • Often associated with indwelling catheters in hospitalized patients 1, 2

Bacteremia/Bloodstream Infections:

  • Community-acquired: Indolent presentation, rarely causes shock (only 3 of 64 cases in one series), high risk of endocarditis (12 of 35 community-acquired cases) 3
  • Nosocomial: More aggressive when polymicrobial (with gram-negative bacilli), shock or DIC develops in 50% of polymicrobial cases 3
  • Fever, chills, hemodynamic instability (in severe cases)
  • Sources: urinary tract (29%), IV catheters (24%), intra-abdominal/surgical wounds (46%), burn wounds (25%), cholangitis (21%) 3

Endocarditis:

  • Subacute presentation typical (fever, new murmur, embolic phenomena)
  • Predominantly affects older men with genitourinary source 4
  • Can involve both normal and previously damaged valves 4

Intra-abdominal Infections:

  • Abscess formation, biliary tract infection, spontaneous bacterial peritonitis
  • Post-operative infections, post-partum endomyometritis
  • Often polymicrobial with other pathogens 1
  • Recent data suggests Enterococcus isolation in ICU peritonitis (41% of cases) is not independently associated with higher mortality 5

Soft Tissue Infections:

  • Burns, decubitus ulcers, diabetic foot ulcers
  • Wounds associated with intestinal surgery
  • Usually polymicrobial 1

Key Clinical Pitfalls:

  • Polymicrobial bacteremia (42% of cases) is NOT associated with endocarditis but carries higher risk of shock 3
  • Cryptogenic bacteremia and pre-existing valvular disease strongly suggest endocarditis 3
  • Enterococcal superinfection commonly follows cephalosporin therapy due to intrinsic resistance 1

Treatment Recommendations

For Vancomycin-Resistant Enterococcus (VRE):

Bacteremia/Systemic Infections:

  • Linezolid 600 mg IV or PO every 12 hours is the first-line treatment for enterococcal infections (Strong recommendation, 1C) 6
  • High-dose daptomycin 8-12 mg/kg IV daily OR in combination with β-lactams (penicillins, cephalosporins, or carbapenems) for VRE bacteremia (Weak recommendation, 2C) 6
  • Treatment duration depends on infection site and clinical response 6

Intra-abdominal Infections:

  • Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours (Weak recommendation, 2D) 6
  • Duration based on clinical response 6

Uncomplicated Urinary Tract Infections:

  • Single-dose fosfomycin 3 g PO (Weak recommendation, 2D) 6
  • Nitrofurantoin 100 mg PO every 6 hours (Weak recommendation, 2D) 6
  • High-dose ampicillin (18-30 g IV daily in divided doses) OR amoxicillin 500 mg IV/PO every 8 hours (Weak recommendation, 2D) 6

For Vancomycin-Susceptible Enterococcus:

Endocarditis:

  • Cell wall-active agent (penicillin G, ampicillin, or vancomycin) PLUS streptomycin or gentamicin (if not high-level resistance) 4
  • 4-week course for uncomplicated cases 4
  • 6-week course for: streptomycin-resistant strains, mitral valve disease, illness >3 months duration, or relapse after previous therapy 4
  • Cure rate approximately 85% with appropriate valve replacement when indicated 4

Complicated UTI/Pyelonephritis (MDR-Enterococcus):

  • Parenteral options: daptomycin, linezolid, quinupristin-dalfopristin 7
  • Oral options for acute uncomplicated UTI: nitrofurantoin, fosfomycin, fluoroquinolones (if susceptible) 7
  • Aminoglycosides or rifampin as adjunctive therapy in serious infections 7

Critical Management Points:

Source Control:

  • Remove indwelling urinary catheters when possible 7
  • Source control is independently protective against 30-day mortality (HR 0.534) and persistent BSI 8
  • Perform follow-up blood cultures—independently protective against mortality (HR 0.403) 8

Asymptomatic Bacteriuria:

  • Routine treatment of asymptomatic bacteriuria with MDR-Enterococcus is NOT recommended 7

Avoid Teicoplanin:

  • Independently associated with persistent BSI (OR 2.023) 8

Prognostic Factors:

  • Immunosuppression (HR 1.638), higher SOFA score (HR 1.205), and primary BSI (HR 1.839) independently predict 30-day mortality 8
  • Polymicrobial enterococcal bacteremia has NO cases of endocarditis but 50% develop shock 3

References

1
Research

Clinical manifestations of enterococcal infection.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

2
Research

Enterococcus, an emerging pathogen.

The Annals of pharmacotherapy, 1993

4
Research

Enterococcal endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

7
Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Related Questions

What oral antibiotic is recommended for an adult with a community‑acquired intra‑abdominal infection after adequate abscess drainage and no known drug allergies?
What is the recommended treatment regimen, dosing, and duration for an Enterococcus infection?
What is the appropriate antibiotic and dosing regimen for a 13-year-old male with streptococcal infection?
What empiric antibiotic regimen should be used for a 78‑year‑old male with an indwelling urinary catheter, urine cultures positive for Enterococcus faecalis and Citrobacter freundii, and no known drug allergies?
In a male patient with a urine culture revealing 30,000 CFU/mL Enterococcus, does this require antimicrobial therapy?
What are the recommended intravenous medication dosing regimens for acute decompensated heart failure?
What diagnostic workup is recommended for suspected nephritic syndrome in a limited-resource clinic setting?
How should I order 1:1 isotonic intravenous fluid replacement to match ostomy output every six hours?
What are the appropriate next‑step evaluations and management for a 68‑year‑old man with diabetes (on metformin), a 46‑pack‑year smoking history (quit 9 years ago), frequent alcohol use, elevated total prostate‑specific antigen, borderline glycated hemoglobin, markedly increased bone‑specific alkaline phosphatase, and dyslipidemia?
Is prednisone appropriate for treating pins-and-needles (paresthesia) sensation?
How should the post‑ictal state be managed in a healthy 6‑month‑to‑5‑year‑old child after a simple febrile seizure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.